US Stock MarketDetailed Quotes
EW Edwards Lifesciences
- 85.250
- +0.190+0.22%
Close May 3 16:00 ET
- 85.750
- +0.500+0.59%
Post 17:35 ET
51.37BMarket Cap36.75P/E (TTM)
86.950High85.200Low2.33MVolume85.850Open85.060Pre Close199.12MTurnover0.39%Turnover Ratio37.07P/E (Static)602.60MShares96.12052wk High7.22P/B50.86BFloat Cap60.57052wk Low--Dividend TTM596.62MShs Float131.730Historical High--Div YieldTTM2.06%Amplitude1.000Historical Low85.560Avg Price1Lot Size
Edwards Lifesciences Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.50%1.6B | 11.56%6B | 13.78%1.53B | 12.27%1.48B | 11.38%1.53B | 8.83%1.46B | 2.86%5.38B | 1.40%1.35B | 0.67%1.32B | -0.15%1.37B |
| Operating revenue | 9.50%1.6B | 11.56%6B | 13.78%1.53B | 12.27%1.48B | 11.38%1.53B | 8.83%1.46B | 2.86%5.38B | 1.40%1.35B | 0.67%1.32B | -0.15%1.37B |
| Cost of revenue | 17.03%385.6M | 27.71%1.38B | 38.39%356.9M | 38.06%350.4M | 27.32%343M | 10.09%329.5M | -13.49%1.08B | -16.67%257.9M | -18.58%253.8M | -19.41%269.4M |
| Gross profit | 7.30%1.21B | 7.51%4.63B | 7.96%1.18B | 6.13%1.13B | 7.49%1.19B | 8.47%1.13B | 7.99%4.3B | 6.88%1.09B | 6.68%1.07B | 6.03%1.1B |
| Operating expense | 11.10%774.9M | 15.27%2.9B | 16.62%748.8M | 16.21%709.9M | 12.00%739M | 16.46%697.5M | 4.78%2.51B | -2.28%642.1M | 1.41%610.9M | 10.00%659.8M |
| Selling and administrative expenses | 12.24%489.7M | 16.40%1.82B | 16.81%478.8M | 16.51%439.6M | 14.60%468.7M | 17.82%436.3M | 4.85%1.57B | -3.39%409.9M | 3.54%377.3M | 9.21%409M |
| -General and administrative expense | ---- | 16.40%1.82B | ---- | ---- | ---- | ---- | 4.85%1.57B | ---- | ---- | ---- |
| Research and development costs | 9.19%285.2M | 13.39%1.07B | 16.28%270M | 15.71%270.3M | 7.78%270.3M | 14.26%261.2M | 4.66%945.2M | -0.26%232.2M | -1.85%233.6M | 11.32%250.8M |
| Operating profit | 1.18%437.7M | -3.38%1.73B | -4.44%428.4M | -7.42%420.6M | 0.79%448.2M | -2.35%432.6M | 12.85%1.79B | 23.46%448.3M | 14.69%454.3M | 0.63%444.7M |
| Net non-operating interest income expense | 91.86%16.5M | 204.29%49.6M | 112.66%16.8M | 118.84%15.1M | 911.11%9.1M | 1,333.33%8.6M | 1,730.00%16.3M | 1,480.00%7.9M | 962.50%6.9M | 190.00%900K |
| Non-operating interest income | ---- | 89.30%67.2M | ---- | ---- | ---- | ---- | 104.02%35.5M | ---- | ---- | ---- |
| Non-operating interest expense | ---- | -8.33%17.6M | ---- | ---- | ---- | ---- | 4.35%19.2M | ---- | ---- | ---- |
| Total other finance cost | -91.86%-16.5M | ---- | ---- | -118.84%-15.1M | -911.11%-9.1M | ---8.6M | ---- | ---- | -962.50%-6.9M | -190.00%-900K |
| Other net income (expense) | -5.16%-44.8M | -362.50%-181.3M | -858.06%-23.5M | 106.68%3.6M | -721.99%-118.8M | -468.00%-42.6M | -133.65%-39.2M | -75.59%3.1M | -1,125.00%-53.9M | -81.74%19.1M |
| Gain on sale of security | ---- | 526.09%9.8M | ---- | ---- | 320.00%2.2M | ---- | -121.30%-2.3M | ---- | ---- | -124.39%-1M |
| Special income (charges) | -13.57%-50.2M | -427.10%-194.5M | -715.91%-27.1M | 95.76%-2.2M | -750.54%-121M | -952.38%-44.2M | -135.65%-36.9M | -60.00%4.4M | -794.83%-51.9M | -81.44%18.6M |
| -Less：Restructuring and merger&acquisition | 5,800.00%41.3M | -136.14%-9M | -71.90%17.2M | --0 | -28.71%-26.9M | 124.14%700K | 120.06%24.9M | 438.12%61.2M | -1,236.36%-12.5M | 79.63%-20.9M |
| -Less:Other special charges | -79.54%8.9M | 1,595.83%203.5M | 115.09%9.9M | -96.58%2.2M | 6,330.43%147.9M | 512.68%43.5M | -41.75%12M | -1,023.94%-65.6M | 1,270.21%64.4M | -4.17%2.3M |
| Other non- operating income (expenses) | 237.50%5.4M | --3.4M | ---6.2M | 390.00%5.8M | ---- | 1,500.00%1.6M | ---- | ---- | -1,100.00%-2M | 400.00%1.5M |
| Income before tax | 2.71%409.4M | -9.58%1.6B | -8.19%421.7M | 7.86%439.3M | -27.16%338.5M | -8.60%398.6M | 3.84%1.77B | 22.06%459.3M | 4.20%407.3M | -14.81%464.7M |
| Income tax | 0.52%58.4M | -19.06%198.7M | -14.61%52M | -12.85%55.6M | -43.40%33M | -7.04%58.1M | 23.43%245.5M | 48.54%60.9M | 25.59%63.8M | 4.11%58.3M |
| Net income | 3.08%351M | -8.05%1.4B | -7.20%369.7M | 11.70%383.7M | -24.83%305.5M | -8.86%340.5M | 1.25%1.52B | 18.82%398.4M | 1.00%343.5M | -16.98%406.4M |
| Net income continuous Operations | 3.08%351M | -8.05%1.4B | -7.20%369.7M | 11.70%383.7M | -24.83%305.5M | -8.86%340.5M | 1.25%1.52B | 18.82%398.4M | 1.00%343.5M | -16.98%406.4M |
| Minority interest income | -900K | -3M | -200K | -1.2M | -1.6M | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the parent company | 3.35%351.9M | -7.85%1.4B | -7.15%369.9M | 12.05%384.9M | -24.43%307.1M | -8.86%340.5M | 1.25%1.52B | 18.82%398.4M | 1.00%343.5M | -16.98%406.4M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 3.35%351.9M | -7.85%1.4B | -7.15%369.9M | 12.05%384.9M | -24.43%307.1M | -8.86%340.5M | 1.25%1.52B | 18.82%398.4M | 1.00%343.5M | -16.98%406.4M |
| Basic earnings per share | 3.57%0.58 | -6.10%2.31 | -6.15%0.61 | 14.55%0.63 | -21.54%0.51 | -6.67%0.56 | 2.07%2.46 | 20.37%0.65 | 0.00%0.55 | -17.72%0.65 |
| Diluted earnings per share | 3.57%0.58 | -5.74%2.3 | -6.15%0.61 | 14.55%0.63 | -23.08%0.5 | -5.08%0.56 | 2.52%2.44 | 22.64%0.65 | 1.85%0.55 | -16.67%0.65 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg